Search results
How Much Upside is Left in Corbus Pharmaceuticals (CRBP)? Wall Street Analysts Think 318.33%
Corbus Pharmaceuticals (CRBP) closed the last trading session at $10.04, gaining 26.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set
Wall Street Analysts See a 159.31% Upside in Verastem (VSTM): Can the Stock Really Move This High?
Verastem (VSTM) closed the last trading session at $6.39, gaining 1.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
C's Turnaround Strengthens Growth Outlook: Should You Buy the Stock?
Citigroup Inc. C reiterated its strategic priorities and financial targets, highlighting strong growth opportunities despite persistent geopolitical and macroeconomic uncertainties. CEO Jane Fraser
Wall Street Analysts See a 29.21% Upside in Remitly Global (RELY): Can the Stock Really Move This High?
Remitly Global, Inc. (RELY) closed the last trading session at $16.98, gaining 28.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set
AeroVironment Touches Down On Value Opportunity
AeroVironment (NASDAQ: AVAV) faces headwinds in 2026, including the end of its SCAR contract and the resulting impact on market sentiment. However, even with analysts reducing targets and guidance
FITB Stock Dips on Lower 2026 Fee Income Outlook, Raises Synergy Target
Shares of Fifth Third Bancorp FITB lost nearly 3.3% as the company trimmed its 2026 non-interest income outlook. At the RBC Capital Markets Global Financial Institutions Conference 2026, Fifth Third
Wall Street Analysts Think Mistras (MG) Could Surge 25.04%: Read This Before Placing a Bet
Mistras (MG) closed the last trading session at $14.26, gaining 1.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts Think Intuitive Surgical (ISRG) Could Surge 29.72%: Read This Before Placing a Bet
Intuitive Surgical, Inc. (ISRG) closed the last trading session at $479.27, gaining 0.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets
Wall Street Analysts Predict a 35.77% Upside in Stantec (STN): Here's What You Should Know
Stantec (STN) closed the last trading session at $88.85, gaining 1.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts See a 103.55% Upside in Q32 Bio (QTTB): Can the Stock Really Move This High?
Shares of Q32 Bio (QTTB) have gained 83.8% over the past four weeks to close the last trading session at $7.04, but there could still be a solid upside left in the stock if short-term price targets
Wall Street Analysts Predict a 52.01% Upside in Descartes Systems (DSGX): Here's What You Should Know
Descartes Systems (DSGX) closed the last trading session at $71.98, gaining 11.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Can BigBear.ai's Strategic Partnerships Expand Its Defense Reach?
BigBear.ai Holdings, Inc. BBAI is expanding its defense technology capabilities through strategic partnerships and targeted technology collaborations. The company focuses on delivering mission-ready
Is CRH a Buy at 16X Earnings? Price Target and Key Risks
CRH plc CRH sits at an interesting crossroads. The stock trades at a discount to broad benchmarks, yet its near-term earnings narrative is getting tougher as estimates drift lower. At the same time
MKSI Gets SBTi Approval for 2030 Science-Based Emission Targets
MKS MKSI shares have surged 148.1% in the past year, outperforming the Zacks Computer & Technology sector’s growth of 31.9%. The surge can be attributed mainly to strong revenue and profit growth